Applications of a human tumour clonogenic cell culture system in gynaecological oncology: review and personal experience.

Abstract

Current and future clinical applications of the Human Tumour Clonogenic Cell Culture (HTC3) system are presented. Advanced gynaecological cancers, especially ovarian, endometrial and cervical carcinomas, require extensive systemic chemotherapy. The HTC3 system seems to be an adequate instrument for individualized chemosensitivity testing in order to choose… (More)

Topics

Cite this paper

@article{Verheijen1984ApplicationsOA, title={Applications of a human tumour clonogenic cell culture system in gynaecological oncology: review and personal experience.}, author={Ren{\'e} H. M. Verheijen and Chester Herman and Peter Kenemans}, journal={European journal of obstetrics, gynecology, and reproductive biology}, year={1984}, volume={17 1}, pages={43-51} }